Evaluation of nirmatrelvir + ritonavir therapy in patients with mild to moderate COVID-19
Background. Coronavirus infection can provoke a number of diseases, ranging from acute respiratory infection to acute respiratory distress syndrome. As the virus mutates, treatment recommendations change to reflect the safest and most effective treatments available. The combined drug nirmatrelvir...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Penza State University Publishing House
2024-03-01
|
| Series: | Известия высших учебных заведений. Поволжский регион: Медицинские науки |
| Subjects: |